Brought to you by 
3M, VaxInnate ally in transdermal vaccine for pandemic flu
28 Oct 2008
Executive Summary
3M Drug Delivery Systems (inhalation and transdermal drug delivery technologies) licensed VaxInnate (developing vaccines for seasonal and pandemic influenza) nonexclusive rights to use its 3M Microstructured Transdermal System to deliver the M2e universal vaccine for pandemic flu.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Transdermal
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
3M, VaxInnate ally in transdermal vaccine for pandemic flu
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice